Stable Istotope Labelled Evinacumab Biosimilar – Anti-ANGPTL3 mAb – Research Grade

Reference: PX-TA1369-SIL-1MG
Product nameStable Istotope Labelled Evinacumab Biosimilar - Anti-ANGPTL3 mAb - Research Grade
SourceCAS 1446419-85-7
SpeciesHomo sapiens
Expression systemMammalian cells
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
Aliases /SynonymsREGN 1500
Related ProductsPX-P4695
NoteFor research use only. Not suitable for clinical or therapeutic use.
ClonalityMonoclonal Antibody
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-ANGPTL3[Homo sapiens] (Evinacumab) Monoclonal Antibody

Evinacumab is a recombinant human IgG4 monoclonal antibody targeting human angiopoietin-like protein 3 (ANGPTL3). The ANGPTL protein family has many physiological functions-including the regulation of lipid metabolism. It has been noted that the loss-of-function mutation of ANGPTL3 leads to hypolipidemia and subsequently reduces cardiovascular risk, while increased function seems to be related to cardiovascular risk. Evinacumab has been used to treat homozygous familial hypercholesterolemia (HoFH). It has been sold under the Evkeeza brand name.


There are no reviews yet.


Be the first to review “Stable Istotope Labelled Evinacumab Biosimilar – Anti-ANGPTL3 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.